Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies

ConditionScabies
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age6-15
SponsorChildren Hospital and Institute of Child Health, Lahore

About this trial

Scabies is highly contagious,pruritic infestation of skin.Various treatment modalities have been used but search for ideal scabicide is ongoing.we wnt to coduct this study to compare the outcome of permethrin verses ivermectin in children for treatment of scabies .This randomized clinical trial will be done in children hospital lahore for 12 months.Sample size of 90 cases;30 in each group will be included through non probability consecutive sampling.Then patient will be randomly divided into 3 groups.In group A patient will be given 5% permethrin topical application to whole body single application. In Group B ,patients will be given topical permethrin for twice application 24 hrs appart ,In group C patients will be given Tablet Ivermectin single dose 200microgram/kg.Then patients will be examined after 2 weeks and 4 weeks for no of lesions and pruritis and cure will be labeled.All this information will be recorded on performa .Data will be entered and analysed by using SPSS version 26.Three groups will be compared for cure by using chi-square test.P value less than and equal to 0.05 will be considered as significant.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 6-15

Both genders

Diagnosed with scabies (as per operational definition)

Disqualifiers

Children with recurrent scabies on medical record

Known allergy to ivermectin or permethrin.

Widespread eczema or impetigo.

Liver dysfunction or renal failure

Trial design

Design model

Parallel

Treatments tested in this trial

  • Permethrin Cream, 5%

    Drug

    Permethrin 5% cream will be given as a single application

  • Permethrin Cream, 5%

    Drug

    Permethrin Cream will be given as twice application

  • Ivermectin 200 µg/kg

    Drug

    Group C will be given Tab Ivermectin

Treatment groups

90 Participants
are divided into 3 treatment groups
Group A: Group AExperimental treatment 1 intervention
Group B: Group BExperimental treatment 1 intervention
Group C: Group CExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Cure of scabies.

Cure will be labeled if greater han 50% reduction in no of lesions and pruritis observed after 4 weeks of treatment.

Time frame
12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: